Clinical Study
Bevacizumab Injection in Patients with Age-Related Macular Degeneration Associated with Poor Initial Visual Acuity
Table 2
Visual acuity (VA) and central retinal thickness (CRT) outcome in patients previously treated with PDT compared with patients without prior PDT.
| | | Patients with prior PDT () | P | Patients without prior PDT () | P |
| | VA(logMAR) | | | | | | (i) At baseline | 1.3 ± 0.24 | | 1.4 ± 0.36 | | | (ii) At final examination | 1.16 ± 0.15 | 0.043 | 1.18 ± 0.38 | 0.001 | | (iii) At 12 months | 1.08 ± 0.2 | 0.039 | 1.28 ± 0.37 | 0.03 |
| | CRT (μm) | | | | | | (i) At baseline | 472.33 ± 61.23 | | 427.11 ± 167.52 | | | (ii) At final examination | 323.4 ± 159.6 | 0.1 | 301 ± 131.08 | 10−4 | | (iii) At 12 months | 312.75 ± 184.9 | 0.18 | 313.31 ± 138.9 | 0.01 |
|
|
LogMAR: logarithm of the minimum angle of resolution; VA: visual acuity; CRT: central retinal thickness; PDT: photodynamic therapy.
|
